NEW YORK, Jan. 8, 2024 /PRNewswire/ — The contact lens solutions market is estimated to grow by USD 540.94 million from 2023 to 2028, according to Technavio. The market is estimated to grow at a CAGR of 3.97% during the forecast period. However, the growth momentum will progress. North America is estimated to contribute 36% to the growth… Continue reading Contact Lens Solutions Market size to grow by USD 540.94 million from 2023 to 2028, Increased preference for contact lenses over spectacles to boost the market- Technavio
Tag: Possible_Terrorism_Warfare
Yacht Charter Market to Generate $ 20202.5 million, Globally, by 2032 at 6.9% CAGR: Allied Market Research
The global yacht charters market has witnessed growth due to rise in water sports and recreation activities along with surge in number of private islands on cruise itineraries. PORTLAND, Ore., Jan. 8, 2024 /PRNewswire/ — Allied Market Research published a report, titled, “Yacht Charter Market by Type (Motorized yacht, Sailing Yacht and Others), Size {(Small… Continue reading Yacht Charter Market to Generate $ 20202.5 million, Globally, by 2032 at 6.9% CAGR: Allied Market Research
Airport Kiosk Market to Reach $5.11 Billion, Globally, by 2032 at 9.4% CAGR: Allied Market Research
The growth of the global airport kiosk is driven by factors such as increase in air passenger traffic globally, improvement in airport infrastructure in developing nations, and increased adoption of touchscreen, multimedia, and biometric kiosks to enhance passenger experience. WILMINGTON, Del., Jan. 8, 2024 /PRNewswire/ — Allied Market Research published a report, titled, “Airport Kiosk Market… Continue reading Airport Kiosk Market to Reach $5.11 Billion, Globally, by 2032 at 9.4% CAGR: Allied Market Research
Contact Lens Solutions Market size to grow by USD 540.94 million from 2023 to 2028, Increased preference for contact lenses over spectacles to boost the market- Technavio
NEW YORK, Jan. 8, 2024 /PRNewswire/ — The contact lens solutions market is estimated to grow by USD 540.94 million from 2023 to 2028, according to Technavio. The market is estimated to grow at a CAGR of 3.97% during the forecast period. However, the growth momentum will progress. North America is estimated to contribute 36% to the growth… Continue reading Contact Lens Solutions Market size to grow by USD 540.94 million from 2023 to 2028, Increased preference for contact lenses over spectacles to boost the market- Technavio
5G in Defense Research Report 2023: Ultra-Reliable Low-Latency Communications (URLLC) – A Game Changer in 5G Defense
DUBLIN, Jan. 8, 2024 /PRNewswire/ — The “5G in Defense Market by Platform (Land, Naval, Airborne), Solution (Communication Network,Chipset, Core Network), End User, Network Type, Installation and Region (North America, Europe, Asia Pacific, LA, MEA) – Global Forecast to 2028″ report has been added to ResearchAndMarkets.com’s offering. The 5G in Defense market is estimated to… Continue reading 5G in Defense Research Report 2023: Ultra-Reliable Low-Latency Communications (URLLC) – A Game Changer in 5G Defense
PENSKE AUTOMOTIVE GROUP COMPLETES RYBROOK ACQUISITION EXPANDING PRESENCE IN THE UNITED KINGDOM
Adds 15 Premium Dealerships Representing Estimated Annualized Revenue of $1 Billion BLOOMFIELD HILLS, Mich., Jan. 8, 2024 /PRNewswire/ — Penske Automotive Group, Inc. (NYSE: PAG), a diversified international transportation services company and one of the world’s premier automotive and commercial truck retailers, today announced that it has completed the acquisition of Rybrook Group Limited consisting of… Continue reading PENSKE AUTOMOTIVE GROUP COMPLETES RYBROOK ACQUISITION EXPANDING PRESENCE IN THE UNITED KINGDOM
BAE Systems to provide critical Mk 45 naval gun systems upgrade to Australian Navy frigates
LOUISVILLE, Ky., Jan. 8, 2024 /PRNewswire/ — BAE Systems was awarded a contract by the Commonwealth of Australia to upgrade existing Mk 45 Mod 2 naval gun systems on Anzac class frigates with a Common Control System (CCS). The upgrade modifies existing Mk 45 systems to eliminate obsolescence issues and extend the life of the… Continue reading BAE Systems to provide critical Mk 45 naval gun systems upgrade to Australian Navy frigates
Airport Kiosk Market to Reach $5.11 Billion, Globally, by 2032 at 9.4% CAGR: Allied Market Research
The growth of the global airport kiosk is driven by factors such as increase in air passenger traffic globally, improvement in airport infrastructure in developing nations, and increased adoption of touchscreen, multimedia, and biometric kiosks to enhance passenger experience. WILMINGTON, Del., Jan. 8, 2024 /PRNewswire/ — Allied Market Research published a report, titled, “Airport Kiosk Market… Continue reading Airport Kiosk Market to Reach $5.11 Billion, Globally, by 2032 at 9.4% CAGR: Allied Market Research
Airport Kiosk Market to Reach $5.11 Billion, Globally, by 2032 at 9.4% CAGR: Allied Market Research
The growth of the global airport kiosk is driven by factors such as increase in air passenger traffic globally, improvement in airport infrastructure in developing nations, and increased adoption of touchscreen, multimedia, and biometric kiosks to enhance passenger experience. WILMINGTON, Del., Jan. 8, 2024 /PRNewswire/ — Allied Market Research published a report, titled, “Airport Kiosk Market… Continue reading Airport Kiosk Market to Reach $5.11 Billion, Globally, by 2032 at 9.4% CAGR: Allied Market Research
Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
HOLON, Israel, Jan. 8, 2024 /PRNewswire/ — Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that Compugen is entitled to receive a $10 million milestone payment from AstraZeneca (LSE/STO/Nasdaq: AZN), after the first patient was dosed in AstraZeneca’s ARTEMIDE-Bil01 trial with rilvegostomig. Rilvegostomig is… Continue reading Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer